Teacher Retirement System of Texas Purchases New Stake in Sotera Health Company (NASDAQ:SHC)

Teacher Retirement System of Texas bought a new stake in Sotera Health Company (NASDAQ:SHC) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 22,774 shares of the company’s stock, valued at approximately $266,000.

A number of other hedge funds have also made changes to their positions in SHC. New York State Teachers Retirement System grew its position in Sotera Health by 1.9% in the first quarter. New York State Teachers Retirement System now owns 59,273 shares of the company’s stock valued at $691,000 after acquiring an additional 1,100 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company’s stock worth $70,000 after buying an additional 6,200 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Sotera Health by 816.3% during the first quarter. GAMMA Investing LLC now owns 37,650 shares of the company’s stock worth $439,000 after buying an additional 33,541 shares in the last quarter. California State Teachers Retirement System grew its position in shares of Sotera Health by 8.0% during the fourth quarter. California State Teachers Retirement System now owns 145,411 shares of the company’s stock worth $1,989,000 after buying an additional 10,778 shares in the last quarter. Finally, Neo Ivy Capital Management grew its position in shares of Sotera Health by 144.7% during the fourth quarter. Neo Ivy Capital Management now owns 105,546 shares of the company’s stock worth $1,443,000 after buying an additional 62,420 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

Shares of SHC opened at $11.06 on Friday. The company has a market capitalization of $3.14 billion, a price-to-earnings ratio of 138.27 and a beta of 1.81. Sotera Health Company has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The company has a debt-to-equity ratio of 5.55, a current ratio of 2.46 and a quick ratio of 2.19. The business’s 50-day moving average is $11.88 and its 200-day moving average is $12.18.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.14 EPS for the quarter, beating the consensus estimate of $0.12 by $0.02. The business had revenue of $254.52 million during the quarter, compared to analysts’ expectations of $245.56 million. Sotera Health had a return on equity of 41.08% and a net margin of 2.24%. The firm’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.13 EPS. Equities research analysts expect that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages recently issued reports on SHC. Barclays reduced their price objective on Sotera Health from $15.00 to $13.00 and set an “overweight” rating on the stock in a research note on Tuesday, June 24th. Piper Sandler dropped their price objective on shares of Sotera Health from $15.00 to $13.00 and set a “neutral” rating on the stock in a report on Wednesday, April 23rd. Wall Street Zen raised shares of Sotera Health from a “hold” rating to a “buy” rating in a report on Saturday, June 28th. Finally, The Goldman Sachs Group upgraded shares of Sotera Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $14.00 to $17.00 in a research note on Monday, May 5th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.